Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan vs esomeprazole for treatment of GERD
ChiCTR2200066637Phase 4Not yet recruiting
- Sponsor
- The University of Hong Kong-Shenzhen Hospital
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in gastroesophageal reflux disease (GERD) comparing Esomeprazole arm with Vonoprazan arm (2 arms). Primary endpoint: GerdQ score. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
vonoprazanesomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on ChiCTR2200066637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066637.